Phase IIa Study of BRY812 Monotherapy in Advanced Gynecological Malignancies
Clinical trial NCT07311538 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07311538
- Sponsor
- BioRay Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-01
- Primary completion
- 2027-12-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.